You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 1, January 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation

M. R. Mainous, P. Tso, R. D. Berg and E. A. Deitch
Department of Surgery, Louisiana State University Medical Center, Shreveport, La.

Bacteria have been documented to translocate from the gut to systemic organs, yet the exact route by which they translocate remains unclear. To determine the route of bacterial translocation, different dosages of zymosan were used to activate complement and cause systemic inflammation. At a zymosan dose of 0.1 mg/g, bacteria translocated only to the mesenteric lymph node complex, whereas at a dose of 0.5 mg/g the bacteria translocated systematically. In rats receiving 0.5-mg/g doses of zymosan, the bacteria appeared to reach systemic organs via the portal blood rather than via the mesenteric lymph, as bacteria were present in 87% of portal blood samples but only 25% of lymph samples. The number of bacteria exiting the portal vein was 11,500 times greater than the number exiting via the lymph. Thus, both the route and extent of bacterial translocation varies based on the magnitude of the inflammatory insult, with the portal blood being the major route of bacterial translocation to systemic organs.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Nitric Oxide Donor LA-419 [S-(6-Nitro-oxi-hexahydro-furo[3,2-b]furan-3-1-il)thioacetate] Prevents Intestinal Dysmotility, Bacterial Translocation, and Inflammation in a Rat Model of Enteritis
Porras et al.
J. Pharmacol. Exp. Ther. 2008;324:740-748.
ABSTRACT | FULL TEXT  

Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid
Llopis et al.
Gut 2005;54:955-959.
ABSTRACT | FULL TEXT  

Reducing Costs and Patient Morbidity in the Enterally Fed Intensive Care Unit Patient
Farber et al.
JPEN J Parenter Enteral Nutr 2005;29:S62-S69.
ABSTRACT | FULL TEXT  

The biological activity of a liposomal complete core lipopolysaccharide vaccine
Erridge et al.
Innate Immunity 2002;8:39-46.
ABSTRACT  

Increased Intestinal Permeability Is Associated with the Development of Multiple Organ Dysfunction Syndrome in Critically Ill ICU Patients
DOIG et al.
Am. J. Respir. Crit. Care Med. 1998;158:444-451.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.